Cagrilintide is a long-acting analogue of amylin. It is being tested to treat obesity and type 2 diabetes by itself and in combination with semaglutide as cagrilintide/semaglutide. [1][2][3][4][5][6]
⚠️ For research purposes only. Not for human consumption.
Reviews
There are no reviews yet.